Norepinephrine vs dopamine for cardiogenic shock
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two blood pressure support medicines (norepinephrine and dopamine) in adults with cardiogenic shock, a condition where the heart cannot pump enough blood. It aims to find which medicine works better for patients with this severe heart condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- You have cardiogenic shock (your heart is not pumping enough blood, causing low blood pressure and signs like confusion or cold, clammy skin).
- Your heart function is significantly impaired, confirmed by tests like echocardiography or heart catheterization.
- You are not already on a heart pump or other mechanical support device.
- You have not received vasoactive drugs (blood pressure medicines) for more than 6 hours before joining.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood pressure targets in people with cardiogenic shock after a heart attack. It looks at whether the lower target can improve outcomes and help evaluate treatment costs.
This trial tests whether setting a personalized blood pressure goal for each person in cardiogenic shock improves recovery compared to standard care. It may help if you have severe shock and can be enrolled within the first 24 hours.
This study is testing a device called an intra-aortic balloon pump (a small balloon placed in your heart's main artery to help it pump) for people in the early stages of cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to see if adding this supportive device early on improves outcomes for patients with heart attacks or other heart problems.
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.
This study compares two medicines—norepinephrine and angiotensin II—to see which one works better at raising blood pressure in people with septic shock (a severe infection that causes dangerously low blood pressure). It aims to find out which approach helps patients recover better.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.